. A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron. 2006 Sep 7;51(5):549-60. PubMed.


Please login to recommend the paper.


  1. The findings may possibly result in a breakthrough in the study of tauopathy, an essetial pathological propety of Alzheimer's disease.

Make a Comment

To make a comment you must login or register.